Company: MYSEW
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001213900-25-115502
Chunk: 19

Company: Myseum, Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 19
---
 of
this prospectus, our authorized capital stock consisted of 180,000,000 shares of common stock, $0.0001 par value per share, and
20,000,000 shares of preferred stock, $0.0001 par value per share, of which 1 share of our preferred stock has been designated as
Series A Preferred Stock and 2,000,000 shares of our preferred stock have been designated as Series B Preferred Stock. As of
November __, 2025, 4,264,329 share of common stock were issued and outstanding, no shares of preferred stock are outstanding, and we
have 17,999,999 shares of undesignated preferred stock available for future designation and issuance. Our Board may establish the
rights and preferences of the preferred stock from time to time.

Common Stock

Voting

Holders of the Company’s common stock are
entitled to one vote per share on all matters voted on by the Company’s shareholders, including the election of directors. The
Company’s Articles of Incorporation and Bylaws do not provide for cumulative voting in the election of directors.

Dividends

Holders of common stock are entitled, subject
to the rights, privileges, restrictions and conditions attaching to any other class of shares ranking in priority to the common stock,
to receive any dividend declared by the board of directors.

Liquidation rights

If the Company is voluntarily or involuntarily
liquidated, dissolved or wound-up, the holders of common stock will be entitled to receive, after distribution in full of the preferential
amounts, if any, all of the remaining assets available for distribution ratably in proportion to the number of shares of common stock
held by them.

Preferred Stock

We currently have authorized 20,000,000 shares of preferred stock,
par value $0.0001, of which 1 share of our preferred stock has been designated as Series A Preferred Stock and 2,000,000 shares of our
preferred stock have been designated as Series B Preferred Stock. As of November __, 2025, there are no shares of preferred stock outstanding
and there are 17,999,999 shares of undesignated preferred stock available for issuance. The Board of Directors is further authorized,
subject to limitations prescribed by law, to fix by resolution or resolutions the designations, powers, preferences and rights, and the
qualifications, limitations or restrictions thereof, of any wholly unissued series of preferred stock, including,